- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to our latest study, the global Vaccine (Include COVID-19) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
This report is a detailed and comprehensive analysis for global Vaccine (Include COVID-19) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Vaccine (Include COVID-19) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Vaccine (Include COVID-19) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Vaccine (Include COVID-19) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Vaccine (Include COVID-19) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vaccine (Include COVID-19)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Vaccine (Include COVID-19) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris and AstraZeneca, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Vaccine (Include COVID-19) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Inactivated Vaccine
Attenuated Vaccine
mRNA
Other
Market segment by Application
Public
Private
Market segment by players, this report covers
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
KM Biologics
Pfizer
Merck
Sinovac
Zhejiang Pukang
Walvax Biotechnology
Bharat Biotech
Serum Institute
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
LG Life Sciences
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Vaccine (Include COVID-19) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Vaccine (Include COVID-19), with revenue, gross margin and global market share of Vaccine (Include COVID-19) from 2018 to 2023.
Chapter 3, the Vaccine (Include COVID-19) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Vaccine (Include COVID-19) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Vaccine (Include COVID-19).
Chapter 13, to describe Vaccine (Include COVID-19) research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Vaccine (Include COVID-19)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Vaccine (Include COVID-19) by Type
1.3.1 Overview: Global Vaccine (Include COVID-19) Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Vaccine (Include COVID-19) Consumption Value Market Share by Type in 2022
1.3.3 Inactivated Vaccine
1.3.4 Attenuated Vaccine
1.3.5 mRNA
1.3.6 Other
1.4 Global Vaccine (Include COVID-19) Market by Application
1.4.1 Overview: Global Vaccine (Include COVID-19) Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Public
1.4.3 Private
1.5 Global Vaccine (Include COVID-19) Market Size & Forecast
1.6 Global Vaccine (Include COVID-19) Market Size and Forecast by Region
1.6.1 Global Vaccine (Include COVID-19) Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Vaccine (Include COVID-19) Market Size by Region, (2018-2029)
1.6.3 North America Vaccine (Include COVID-19) Market Size and Prospect (2018-2029)
1.6.4 Europe Vaccine (Include COVID-19) Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Vaccine (Include COVID-19) Market Size and Prospect (2018-2029)
1.6.6 South America Vaccine (Include COVID-19) Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Vaccine (Include COVID-19) Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Vaccine (Include COVID-19) Product and Solutions
2.1.4 Sanofi Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments and Future Plans
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Vaccine (Include COVID-19) Product and Solutions
2.2.4 CSL Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CSL Recent Developments and Future Plans
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Vaccine (Include COVID-19) Product and Solutions
2.3.4 GSK Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GSK Recent Developments and Future Plans
2.4 Viatris
2.4.1 Viatris Details
2.4.2 Viatris Major Business
2.4.3 Viatris Vaccine (Include COVID-19) Product and Solutions
2.4.4 Viatris Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Viatris Recent Developments and Future Plans
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Vaccine (Include COVID-19) Product and Solutions
2.5.4 AstraZeneca Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AstraZeneca Recent Developments and Future Plans
2.6 Hualan Bio
2.6.1 Hualan Bio Details
2.6.2 Hualan Bio Major Business
2.6.3 Hualan Bio Vaccine (Include COVID-19) Product and Solutions
2.6.4 Hualan Bio Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hualan Bio Recent Developments and Future Plans
2.7 Changchun Institute of Biological
2.7.1 Changchun Institute of Biological Details
2.7.2 Changchun Institute of Biological Major Business
2.7.3 Changchun Institute of Biological Vaccine (Include COVID-19) Product and Solutions
2.7.4 Changchun Institute of Biological Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Changchun Institute of Biological Recent Developments and Future Plans
2.8 Sinovac
2.8.1 Sinovac Details
2.8.2 Sinovac Major Business
2.8.3 Sinovac Vaccine (Include COVID-19) Product and Solutions
2.8.4 Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sinovac Recent Developments and Future Plans
2.9 KM Biologics
2.9.1 KM Biologics Details
2.9.2 KM Biologics Major Business
2.9.3 KM Biologics Vaccine (Include COVID-19) Product and Solutions
2.9.4 KM Biologics Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 KM Biologics Recent Developments and Future Plans
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Vaccine (Include COVID-19) Product and Solutions
2.10.4 Pfizer Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Pfizer Recent Developments and Future Plans
2.11 Merck
2.11.1 Merck Details
2.11.2 Merck Major Business
2.11.3 Merck Vaccine (Include COVID-19) Product and Solutions
2.11.4 Merck Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Merck Recent Developments and Future Plans
2.12 Sinovac
2.12.1 Sinovac Details
2.12.2 Sinovac Major Business
2.12.3 Sinovac Vaccine (Include COVID-19) Product and Solutions
2.12.4 Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sinovac Recent Developments and Future Plans
2.13 Zhejiang Pukang
2.13.1 Zhejiang Pukang Details
2.13.2 Zhejiang Pukang Major Business
2.13.3 Zhejiang Pukang Vaccine (Include COVID-19) Product and Solutions
2.13.4 Zhejiang Pukang Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Zhejiang Pukang Recent Developments and Future Plans
2.14 Walvax Biotechnology
2.14.1 Walvax Biotechnology Details
2.14.2 Walvax Biotechnology Major Business
2.14.3 Walvax Biotechnology Vaccine (Include COVID-19) Product and Solutions
2.14.4 Walvax Biotechnology Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Walvax Biotechnology Recent Developments and Future Plans
2.15 Bharat Biotech
2.15.1 Bharat Biotech Details
2.15.2 Bharat Biotech Major Business
2.15.3 Bharat Biotech Vaccine (Include COVID-19) Product and Solutions
2.15.4 Bharat Biotech Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Bharat Biotech Recent Developments and Future Plans
2.16 Serum Institute
2.16.1 Serum Institute Details
2.16.2 Serum Institute Major Business
2.16.3 Serum Institute Vaccine (Include COVID-19) Product and Solutions
2.16.4 Serum Institute Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Serum Institute Recent Developments and Future Plans
2.17 Panacea Biotec Ltd
2.17.1 Panacea Biotec Ltd Details
2.17.2 Panacea Biotec Ltd Major Business
2.17.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Product and Solutions
2.17.4 Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Panacea Biotec Ltd Recent Developments and Future Plans
2.18 Bio-Med
2.18.1 Bio-Med Details
2.18.2 Bio-Med Major Business
2.18.3 Bio-Med Vaccine (Include COVID-19) Product and Solutions
2.18.4 Bio-Med Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Bio-Med Recent Developments and Future Plans
2.19 Halfkin Bio-Pharmaceuticals
2.19.1 Halfkin Bio-Pharmaceuticals Details
2.19.2 Halfkin Bio-Pharmaceuticals Major Business
2.19.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product and Solutions
2.19.4 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Halfkin Bio-Pharmaceuticals Recent Developments and Future Plans
2.20 LG Life Sciences
2.20.1 LG Life Sciences Details
2.20.2 LG Life Sciences Major Business
2.20.3 LG Life Sciences Vaccine (Include COVID-19) Product and Solutions
2.20.4 LG Life Sciences Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 LG Life Sciences Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Vaccine (Include COVID-19) Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Vaccine (Include COVID-19) by Company Revenue
3.2.2 Top 3 Vaccine (Include COVID-19) Players Market Share in 2022
3.2.3 Top 6 Vaccine (Include COVID-19) Players Market Share in 2022
3.3 Vaccine (Include COVID-19) Market: Overall Company Footprint Analysis
3.3.1 Vaccine (Include COVID-19) Market: Region Footprint
3.3.2 Vaccine (Include COVID-19) Market: Company Product Type Footprint
3.3.3 Vaccine (Include COVID-19) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Vaccine (Include COVID-19) Consumption Value and Market Share by Type (2018-2023)
4.2 Global Vaccine (Include COVID-19) Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Vaccine (Include COVID-19) Consumption Value Market Share by Application (2018-2023)
5.2 Global Vaccine (Include COVID-19) Market Forecast by Application (2024-2029)
6 North America
6.1 North America Vaccine (Include COVID-19) Consumption Value by Type (2018-2029)
6.2 North America Vaccine (Include COVID-19) Consumption Value by Application (2018-2029)
6.3 North America Vaccine (Include COVID-19) Market Size by Country
6.3.1 North America Vaccine (Include COVID-19) Consumption Value by Country (2018-2029)
6.3.2 United States Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
6.3.3 Canada Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
6.3.4 Mexico Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Vaccine (Include COVID-19) Consumption Value by Type (2018-2029)
7.2 Europe Vaccine (Include COVID-19) Consumption Value by Application (2018-2029)
7.3 Europe Vaccine (Include COVID-19) Market Size by Country
7.3.1 Europe Vaccine (Include COVID-19) Consumption Value by Country (2018-2029)
7.3.2 Germany Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
7.3.3 France Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
7.3.5 Russia Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
7.3.6 Italy Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Vaccine (Include COVID-19) Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Vaccine (Include COVID-19) Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Vaccine (Include COVID-19) Market Size by Region
8.3.1 Asia-Pacific Vaccine (Include COVID-19) Consumption Value by Region (2018-2029)
8.3.2 China Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
8.3.3 Japan Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
8.3.4 South Korea Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
8.3.5 India Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
8.3.7 Australia Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
9 South America
9.1 South America Vaccine (Include COVID-19) Consumption Value by Type (2018-2029)
9.2 South America Vaccine (Include COVID-19) Consumption Value by Application (2018-2029)
9.3 South America Vaccine (Include COVID-19) Market Size by Country
9.3.1 South America Vaccine (Include COVID-19) Consumption Value by Country (2018-2029)
9.3.2 Brazil Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
9.3.3 Argentina Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Vaccine (Include COVID-19) Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Vaccine (Include COVID-19) Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Vaccine (Include COVID-19) Market Size by Country
10.3.1 Middle East & Africa Vaccine (Include COVID-19) Consumption Value by Country (2018-2029)
10.3.2 Turkey Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
10.3.4 UAE Vaccine (Include COVID-19) Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Vaccine (Include COVID-19) Market Drivers
11.2 Vaccine (Include COVID-19) Market Restraints
11.3 Vaccine (Include COVID-19) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Vaccine (Include COVID-19) Industry Chain
12.2 Vaccine (Include COVID-19) Upstream Analysis
12.3 Vaccine (Include COVID-19) Midstream Analysis
12.4 Vaccine (Include COVID-19) Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Vaccine (Include COVID-19) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Vaccine (Include COVID-19) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Vaccine (Include COVID-19) Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Vaccine (Include COVID-19) Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Sanofi Company Information, Head Office, and Major Competitors
Table 6. Sanofi Major Business
Table 7. Sanofi Vaccine (Include COVID-19) Product and Solutions
Table 8. Sanofi Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Sanofi Recent Developments and Future Plans
Table 10. CSL Company Information, Head Office, and Major Competitors
Table 11. CSL Major Business
Table 12. CSL Vaccine (Include COVID-19) Product and Solutions
Table 13. CSL Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. CSL Recent Developments and Future Plans
Table 15. GSK Company Information, Head Office, and Major Competitors
Table 16. GSK Major Business
Table 17. GSK Vaccine (Include COVID-19) Product and Solutions
Table 18. GSK Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. GSK Recent Developments and Future Plans
Table 20. Viatris Company Information, Head Office, and Major Competitors
Table 21. Viatris Major Business
Table 22. Viatris Vaccine (Include COVID-19) Product and Solutions
Table 23. Viatris Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Viatris Recent Developments and Future Plans
Table 25. AstraZeneca Company Information, Head Office, and Major Competitors
Table 26. AstraZeneca Major Business
Table 27. AstraZeneca Vaccine (Include COVID-19) Product and Solutions
Table 28. AstraZeneca Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. AstraZeneca Recent Developments and Future Plans
Table 30. Hualan Bio Company Information, Head Office, and Major Competitors
Table 31. Hualan Bio Major Business
Table 32. Hualan Bio Vaccine (Include COVID-19) Product and Solutions
Table 33. Hualan Bio Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Hualan Bio Recent Developments and Future Plans
Table 35. Changchun Institute of Biological Company Information, Head Office, and Major Competitors
Table 36. Changchun Institute of Biological Major Business
Table 37. Changchun Institute of Biological Vaccine (Include COVID-19) Product and Solutions
Table 38. Changchun Institute of Biological Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Changchun Institute of Biological Recent Developments and Future Plans
Table 40. Sinovac Company Information, Head Office, and Major Competitors
Table 41. Sinovac Major Business
Table 42. Sinovac Vaccine (Include COVID-19) Product and Solutions
Table 43. Sinovac Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Sinovac Recent Developments and Future Plans
Table 45. KM Biologics Company Information, Head Office, and Major Competitors
Table 46. KM Biologics Major Business
Table 47. KM Biologics Vaccine (Include COVID-19) Product and Solutions
Table 48. KM Biologics Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. KM Biologics Recent Developments and Future Plans
Table 50. Pfizer Company Information, Head Office, and Major Competitors
Table 51. Pfizer Major Business
Table 52. Pfizer Vaccine (Include COVID-19) Product and Solutions
Table 53. Pfizer Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Pfizer Recent Developments and Future Plans
Table 55. Merck Company Information, Head Office, and Major Competitors
Table 56. Merck Major Business
Table 57. Merck Vaccine (Include COVID-19) Product and Solutions
Table 58. Merck Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Merck Recent Developments and Future Plans
Table 60. Sinovac Company Information, Head Office, and Major Competitors
Table 61. Sinovac Major Business
Table 62. Sinovac Vaccine (Include COVID-19) Product and Solutions
Table 63. Sinovac Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Sinovac Recent Developments and Future Plans
Table 65. Zhejiang Pukang Company Information, Head Office, and Major Competitors
Table 66. Zhejiang Pukang Major Business
Table 67. Zhejiang Pukang Vaccine (Include COVID-19) Product and Solutions
Table 68. Zhejiang Pukang Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Zhejiang Pukang Recent Developments and Future Plans
Table 70. Walvax Biotechnology Company Information, Head Office, and Major Competitors
Table 71. Walvax Biotechnology Major Business
Table 72. Walvax Biotechnology Vaccine (Include COVID-19) Product and Solutions
Table 73. Walvax Biotechnology Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Walvax Biotechnology Recent Developments and Future Plans
Table 75. Bharat Biotech Company Information, Head Office, and Major Competitors
Table 76. Bharat Biotech Major Business
Table 77. Bharat Biotech Vaccine (Include COVID-19) Product and Solutions
Table 78. Bharat Biotech Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Bharat Biotech Recent Developments and Future Plans
Table 80. Serum Institute Company Information, Head Office, and Major Competitors
Table 81. Serum Institute Major Business
Table 82. Serum Institute Vaccine (Include COVID-19) Product and Solutions
Table 83. Serum Institute Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Serum Institute Recent Developments and Future Plans
Table 85. Panacea Biotec Ltd Company Information, Head Office, and Major Competitors
Table 86. Panacea Biotec Ltd Major Business
Table 87. Panacea Biotec Ltd Vaccine (Include COVID-19) Product and Solutions
Table 88. Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Panacea Biotec Ltd Recent Developments and Future Plans
Table 90. Bio-Med Company Information, Head Office, and Major Competitors
Table 91. Bio-Med Major Business
Table 92. Bio-Med Vaccine (Include COVID-19) Product and Solutions
Table 93. Bio-Med Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Bio-Med Recent Developments and Future Plans
Table 95. Halfkin Bio-Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 96. Halfkin Bio-Pharmaceuticals Major Business
Table 97. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product and Solutions
Table 98. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Halfkin Bio-Pharmaceuticals Recent Developments and Future Plans
Table 100. LG Life Sciences Company Information, Head Office, and Major Competitors
Table 101. LG Life Sciences Major Business
Table 102. LG Life Sciences Vaccine (Include COVID-19) Product and Solutions
Table 103. LG Life Sciences Vaccine (Include COVID-19) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. LG Life Sciences Recent Developments and Future Plans
Table 105. Global Vaccine (Include COVID-19) Revenue (USD Million) by Players (2018-2023)
Table 106. Global Vaccine (Include COVID-19) Revenue Share by Players (2018-2023)
Table 107. Breakdown of Vaccine (Include COVID-19) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 108. Market Position of Players in Vaccine (Include COVID-19), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 109. Head Office of Key Vaccine (Include COVID-19) Players
Table 110. Vaccine (Include COVID-19) Market: Company Product Type Footprint
Table 111. Vaccine (Include COVID-19) Market: Company Product Application Footprint
Table 112. Vaccine (Include COVID-19) New Market Entrants and Barriers to Market Entry
Table 113. Vaccine (Include COVID-19) Mergers, Acquisition, Agreements, and Collaborations
Table 114. Global Vaccine (Include COVID-19) Consumption Value (USD Million) by Type (2018-2023)
Table 115. Global Vaccine (Include COVID-19) Consumption Value Share by Type (2018-2023)
Table 116. Global Vaccine (Include COVID-19) Consumption Value Forecast by Type (2024-2029)
Table 117. Global Vaccine (Include COVID-19) Consumption Value by Application (2018-2023)
Table 118. Global Vaccine (Include COVID-19) Consumption Value Forecast by Application (2024-2029)
Table 119. North America Vaccine (Include COVID-19) Consumption Value by Type (2018-2023) & (USD Million)
Table 120. North America Vaccine (Include COVID-19) Consumption Value by Type (2024-2029) & (USD Million)
Table 121. North America Vaccine (Include COVID-19) Consumption Value by Application (2018-2023) & (USD Million)
Table 122. North America Vaccine (Include COVID-19) Consumption Value by Application (2024-2029) & (USD Million)
Table 123. North America Vaccine (Include COVID-19) Consumption Value by Country (2018-2023) & (USD Million)
Table 124. North America Vaccine (Include COVID-19) Consumption Value by Country (2024-2029) & (USD Million)
Table 125. Europe Vaccine (Include COVID-19) Consumption Value by Type (2018-2023) & (USD Million)
Table 126. Europe Vaccine (Include COVID-19) Consumption Value by Type (2024-2029) & (USD Million)
Table 127. Europe Vaccine (Include COVID-19) Consumption Value by Application (2018-2023) & (USD Million)
Table 128. Europe Vaccine (Include COVID-19) Consumption Value by Application (2024-2029) & (USD Million)
Table 129. Europe Vaccine (Include COVID-19) Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe Vaccine (Include COVID-19) Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific Vaccine (Include COVID-19) Consumption Value by Type (2018-2023) & (USD Million)
Table 132. Asia-Pacific Vaccine (Include COVID-19) Consumption Value by Type (2024-2029) & (USD Million)
Table 133. Asia-Pacific Vaccine (Include COVID-19) Consumption Value by Application (2018-2023) & (USD Million)
Table 134. Asia-Pacific Vaccine (Include COVID-19) Consumption Value by Application (2024-2029) & (USD Million)
Table 135. Asia-Pacific Vaccine (Include COVID-19) Consumption Value by Region (2018-2023) & (USD Million)
Table 136. Asia-Pacific Vaccine (Include COVID-19) Consumption Value by Region (2024-2029) & (USD Million)
Table 137. South America Vaccine (Include COVID-19) Consumption Value by Type (2018-2023) & (USD Million)
Table 138. South America Vaccine (Include COVID-19) Consumption Value by Type (2024-2029) & (USD Million)
Table 139. South America Vaccine (Include COVID-19) Consumption Value by Application (2018-2023) & (USD Million)
Table 140. South America Vaccine (Include COVID-19) Consumption Value by Application (2024-2029) & (USD Million)
Table 141. South America Vaccine (Include COVID-19) Consumption Value by Country (2018-2023) & (USD Million)
Table 142. South America Vaccine (Include COVID-19) Consumption Value by Country (2024-2029) & (USD Million)
Table 143. Middle East & Africa Vaccine (Include COVID-19) Consumption Value by Type (2018-2023) & (USD Million)
Table 144. Middle East & Africa Vaccine (Include COVID-19) Consumption Value by Type (2024-2029) & (USD Million)
Table 145. Middle East & Africa Vaccine (Include COVID-19) Consumption Value by Application (2018-2023) & (USD Million)
Table 146. Middle East & Africa Vaccine (Include COVID-19) Consumption Value by Application (2024-2029) & (USD Million)
Table 147. Middle East & Africa Vaccine (Include COVID-19) Consumption Value by Country (2018-2023) & (USD Million)
Table 148. Middle East & Africa Vaccine (Include COVID-19) Consumption Value by Country (2024-2029) & (USD Million)
Table 149. Vaccine (Include COVID-19) Raw Material
Table 150. Key Suppliers of Vaccine (Include COVID-19) Raw Materials
List of Figures
Figure 1. Vaccine (Include COVID-19) Picture
Figure 2. Global Vaccine (Include COVID-19) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Vaccine (Include COVID-19) Consumption Value Market Share by Type in 2022
Figure 4. Inactivated Vaccine
Figure 5. Attenuated Vaccine
Figure 6. mRNA
Figure 7. Other
Figure 8. Global Vaccine (Include COVID-19) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Vaccine (Include COVID-19) Consumption Value Market Share by Application in 2022
Figure 10. Public Picture
Figure 11. Private Picture
Figure 12. Global Vaccine (Include COVID-19) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Vaccine (Include COVID-19) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Vaccine (Include COVID-19) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Vaccine (Include COVID-19) Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Vaccine (Include COVID-19) Consumption Value Market Share by Region in 2022
Figure 17. North America Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Vaccine (Include COVID-19) Revenue Share by Players in 2022
Figure 23. Vaccine (Include COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Vaccine (Include COVID-19) Market Share in 2022
Figure 25. Global Top 6 Players Vaccine (Include COVID-19) Market Share in 2022
Figure 26. Global Vaccine (Include COVID-19) Consumption Value Share by Type (2018-2023)
Figure 27. Global Vaccine (Include COVID-19) Market Share Forecast by Type (2024-2029)
Figure 28. Global Vaccine (Include COVID-19) Consumption Value Share by Application (2018-2023)
Figure 29. Global Vaccine (Include COVID-19) Market Share Forecast by Application (2024-2029)
Figure 30. North America Vaccine (Include COVID-19) Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Vaccine (Include COVID-19) Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Vaccine (Include COVID-19) Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Vaccine (Include COVID-19) Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Vaccine (Include COVID-19) Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Vaccine (Include COVID-19) Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 40. France Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Vaccine (Include COVID-19) Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Vaccine (Include COVID-19) Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Vaccine (Include COVID-19) Consumption Value Market Share by Region (2018-2029)
Figure 47. China Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 50. India Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Vaccine (Include COVID-19) Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Vaccine (Include COVID-19) Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Vaccine (Include COVID-19) Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Vaccine (Include COVID-19) Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Vaccine (Include COVID-19) Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Vaccine (Include COVID-19) Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Vaccine (Include COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 64. Vaccine (Include COVID-19) Market Drivers
Figure 65. Vaccine (Include COVID-19) Market Restraints
Figure 66. Vaccine (Include COVID-19) Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Vaccine (Include COVID-19) in 2022
Figure 69. Manufacturing Process Analysis of Vaccine (Include COVID-19)
Figure 70. Vaccine (Include COVID-19) Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
